GTS Securities’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-4,028
Closed -$252K 1546
2025
Q3
$252K Buy
+4,028
New +$219K 0.01% 1152
2024
Q3
Sell
-19,351
Closed -$548K 4195
2024
Q2
$559K Buy
19,351
+9,645
+99% +$225K ﹤0.01% 2598
2024
Q1
$200K Buy
+9,706
New +$208K ﹤0.01% 3347

Other funds holding GH

GTS Securities's GH Position: Q4 2025 in Review

GTS Securities sold out of Guardant Health (GH) in Q4 2025, closing a stake of 4,028 shares — an estimated $252K sold.

GTS Securities first reported a position in GH in Q1 2024 and held it in 3 quarters. The position peaked at $559K in Q2 2024. 495 funds tracked by Wall St. Rank hold GH as of Q4 2025.

  • GTS Securities reported no remaining Guardant Health position as of Q4 2025 after selling out during the quarter.
  • GTS Securities sold 4,028 Guardant Health shares in Q4 2025, an estimated $252K.
  • GTS Securities first reported a position in Guardant Health in Q1 2024 and held it in 3 quarters.
  • GTS Securities's Guardant Health position peaked at $559K in Q2 2024.
  • 495 funds tracked by Wall St. Rank held Guardant Health as of Q4 2025.

Based on GTS Securities's 13F filing for Q4 2025, filed 13 Feb 2026.